BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26655607)

  • 1. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.
    Nagiel A; Freund KB; Spaide RF; Munch IC; Larsen M; Sarraf D
    Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
    Introini U; Torres Gimeno A; Scotti F; Setaccioli M; Giatsidis S; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair mechanism of retinal pigment epithelial tears in age-related macular degeneration.
    Mukai R; Sato T; Kishi S
    Retina; 2015 Mar; 35(3):473-80. PubMed ID: 25207945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
    Shin JY; Choi M; Chung B; Byeon SH
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment.
    Clemens CR; Bastian N; Alten F; Milojcic C; Heiduschka P; Eter N
    Acta Ophthalmol; 2014 Feb; 92(1):e50-6. PubMed ID: 23819839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPATIAL PATTERN OF RETINAL PIGMENT EPITHELIUM TEAR DEVELOPMENT AND PROGRESSION AFTER ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Fukui T; Ishikawa K; Shiose S; Kano K; Mori K; Notomi S; Sonoda KH
    Retin Cases Brief Rep; 2024 May; 18(3):371-377. PubMed ID: 36730109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal anti-VEGF therapy for vascularized pigment epithelium detachment in age-related macular degeneration.
    Giansanti F; Bacherini D; Giacomelli G; Virgili G; Finocchio L; Fiore T; Vannozzi L; Menchini U
    Eur J Ophthalmol; 2014; 24(3):402-8. PubMed ID: 24242217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.
    Hoerster R; Muether PS; Sitnilska V; Kirchhof B; Fauser S
    Retina; 2014 Sep; 34(9):1767-73. PubMed ID: 24936942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography.
    Inoue M; Arakawa A; Yamane S; Kadonosono K
    Br J Ophthalmol; 2014 Jul; 98(7):956-60. PubMed ID: 24599418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD.
    Gutfleisch M; Heimes B; Schumacher M; Dietzel M; Lommatzsch A; Bird A; Pauleikhoff D
    Eye (Lond); 2011 Sep; 25(9):1181-6. PubMed ID: 21701525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of repeated anti-vascular endothelial growth factor therapy in eyes with retinal pigment epithelial tears.
    Moreira CA; Arana LA; Zago RJ
    Retina; 2013 Feb; 33(2):277-81. PubMed ID: 23023526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new grading system for retinal pigment epithelial tears.
    Sarraf D; Reddy S; Chiang A; Yu F; Jain A
    Retina; 2010; 30(7):1039-45. PubMed ID: 20458264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography.
    Nagiel A; Sarraf D; Sadda SR; Spaide RF; Jung JJ; Bhavsar KV; Ameri H; Querques G; Freund KB
    Retina; 2015 Apr; 35(4):638-47. PubMed ID: 25650713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal anti-vascular endothelial growth factor for retinal angiomatous proliferation in treatment-naive eyes: long-term functional and anatomical results using a modified PrONTO-style regimen.
    Gharbiya M; Parisi F; Cruciani F; Bozzoni-Pantaleoni F; Pranno F; Abdolrahimzadeh S
    Retina; 2014 Feb; 34(2):298-305. PubMed ID: 23807188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy.
    Sarraf D; Chan C; Rahimy E; Abraham P
    Retina; 2013 Sep; 33(8):1551-7. PubMed ID: 23652578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.